Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 1
|
pp. 872–910
XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis
Back to article
Figure 10
(10 of 14)
−
100%
+
Figure 10.
The relationship between XRCC1 expression and pan-cancer molecular subtypes.
(
A
) in BRCA, (
B
) in GBM, (
C
) in HNSC, (
D
) in KIRP, (
E
) in LGG, (
F
) in LIHC, (
G
) in OV, (
H
) in PCPG, (
I
) in PRAD, (
J
) in READ, (
K
) in STAD, (
L
) in UCEC.
